Clinical Practice

From Panel Results to Plate: Building an Elimination and Reintroduction Plan

A 382-food report is not a diet plan. Here is how clinicians turn multi-marker results into a structured elimination and reintroduction sequence patients can actually follow.

A results report covering 382 foods and four immune markers is a starting document, not a prescription. It tells you where markers linked to specific foods are elevated. What it cannot tell you is which of those foods matters most for the person sitting in front of you, in what order to remove them, or how to confirm anything once they come back. That judgement is yours, and it is the part patients are actually paying for.

The practitioners who get the most out of IS382 COMPLETE tend to treat the report the way they would treat any lab panel: as one input alongside history, symptom pattern, and dietary reality. Below is a practical way to structure that work.

Read the Report Against the History, Not in Isolation

Before you touch a food list, put the report next to the intake notes. Marker elevations that line up with a symptom the patient has already described carry more weight in planning than elevations attached to foods the patient rarely eats. A high IgG signal for a food eaten daily is a different planning problem from the same signal for a food eaten twice a year.

This is also where the distinction between markers earns its keep. IgE-linked findings raise immediate-reaction questions that belong in a different conversation, and often a different referral pathway, than delayed-pattern findings. Complement C3b/d changes the shape of the plan again, because complement can amplify a reaction substantially — which means a food with modest immunoglobulin signal but complement involvement may deserve more attention than its position on the list suggests.

Sequence the Removal Rather Than Removing Everything

The most common failure in elimination work is scope. Hand a patient a list of thirty foods to drop and you have created a project they will abandon in week two, and you will learn nothing from the attempt.

A tighter approach is to select a small group of foods for the first phase, chosen on three grounds: strength of the marker findings, frequency of intake, and how plausibly the food connects to the presenting complaint. Everything else stays on a watch list for later phases. This keeps the intervention small enough to complete and specific enough to interpret.

It also protects the patient's nutrition. This is where dietitians have a clear advantage over other providers running the same panel — replacing removed foods with adequate substitutes is routine work for a dietitian and guesswork for almost everyone else. Practices without that skill in-house often build a referral relationship for exactly this step.

Reintroduction Is Where You Learn Something

Removal phases generate hypotheses. Reintroduction tests them. If a patient never systematically returns foods to the diet, you finish the protocol with no more clinical certainty than you started with, and often with a permanently and unnecessarily narrowed diet.

Structured reintroduction means one food at a time, in a defined amount, with a gap before the next, and a written record. Ask patients to track:

• What was eaten, how much, and when
• Any change in digestion, energy, skin, joints, or sleep within the following days
• Whether the same food produces the same response on a second exposure

That last point separates tolerance from a repeatable pattern, and it is the difference between a durable plan and a food fear.

Why Inflammation-Focused Practices Are Adding This

Chiropractors working with patients whose musculoskeletal complaints keep returning have an obvious interest here. When soft-tissue irritability or joint discomfort recurs on a schedule that adjustments alone do not explain, diet-driven inflammatory load is a reasonable line of enquiry. Panel results give that conversation something concrete to work from, rather than a generic instruction to eat better.

Given that NIH studies show at least 20% of the American population have food sensitivities, a caseload of any size will contain patients for whom this line of enquiry is relevant. That is a practical argument for having a pathway ready rather than referring the question out.

At-Home Collection and the Compliance Question

Protocols fail on logistics as often as on clinical reasoning. Serum collection at home removes the draw appointment, the travel, and the scheduling friction that stops patients converting from "interested" to "tested." For the practice, it means no new equipment, no phlebotomy chair, and no additional chair time — the consultation happens around the results rather than around the collection.

For union members, the cost barrier disappears entirely where testing is covered through insurance, which changes the conversation from whether to test to when. Providers serving union populations generally find it worth building the results consultation into a standard visit slot from the outset.

A Service Line, Not a Product

The testing itself is the least interesting part of this offering. The service is the interpretation, the sequenced plan, the reintroduction schedule, and the follow-up visits that structure creates. That is what supports patient retention and what makes this a genuine addition to a practice rather than a one-off sale. Build the protocol first, and the rest follows.